Savara Inc Long-term Debt and Lease Obligation
Savara Inc (SVRA) had Long-term Debt and Lease Obligation of $25.00 thousand as of 2015-06-30, per its 10-Q filed 2015-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2015-08-12
- 2015-06-30: Long-term Debt and Lease Obligation $25.00K.
- 2015-03-31: Long-term Debt and Lease Obligation $27.00K.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2015-06-30 | $25.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $27.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |